We read with great interest the article by Brandstrup et al 1 reporting the reduction of complications by a restricted intravenous fluid regimen in patients undergoing elective colorectal surgery. Some aspects of this work deserve further comment.
nary disease." Because only 1% to 3% of patients were classified as ASA III, the prevalence of severe coronary artery or respiratory disease must have been small. Thus, the authors' transfusion practice to achieve a hematocrit of 35% "if cardiovascular disease was present" seems questionable and may explain the surprisingly high transfusion rate of 28%. Considering the greater overall cardiovascular complication rate in the standard group, the reader also would like to know if invasive hemodynamic monitoring (central venous pressure, arterial pressure) was routinely performed to guide perioperative volume replacement, how many patients required dopamine/ephedrine treatment at what doses, and which medication subjects were taking prior to surgery (␤-blockers, ACE inhibitors, calcium antagonists). In light of the overall high rates of tissue-healing complications (16% in the restricted group, 31% in the standard group) and infections including sepsis, pneumonia, and cystitis, statements like "antibiotic ... prophylaxes were administered according to department routine" need to be more specific (type, dose, and timing of antibiotic treatment).
All patients received thoracic epidural analgesia "following the routine of the centers." Of course anesthesiologists are curious about the specifics and goals of this routine, in particular about the exact catheter insertion site, the spread of epidural sensory blockade pre-and postoperatively, as well as the success (as assessed by visual analogue scales) and duration of epidural analgesia after surgery. This leads to the final questions that were not addressed in the article: how many days did patients spend in hospital and was hospital stay affected by intravenous fluid restriction?
New Technique for Liver Resection Using Heat Coagulative Necrosis
To the Editor:
W ith great interest, I read the article by Weber and colleagues 1 titled "New Technique for Liver Resection Using Heat Coagulative Necrosis." The authors described a new innovative technique using radiofrequency coagulative energy for liver resection, which significantly decreased blood loss during the procedure. Because blood loss remains a major problem for hepatic resection, this technique would become an excellent method if it works consistently as they have described. I have been using radiofrequency thermal ablation treatment of liver tumors for more than 5 years 2 and actually have attempted the similar radiofrequency coagulative method to assist hepatic resection to reduce blood loss. The radiofrequency ablation system (RITA Medical Systems, Mountain View, CA) I have been using is different from their system (Radionics) but has been effective in ablating various types of liver tumors. However, when I used the radiofrequency energy to assist hepatic resection, it did not work as effectively as what the authors described in their article. I have several questions, which would be helpful to use this technique in the future for the readers, as well as for me. I would like to know the size and number of liver tumors they resected because it must have determined the extent of surgical resection they performed. Although they have described in the Discussion that this technique has not been used for major resection, it seems that they actually used this for relatively major resections, such as bisegmentectomies. If so, the median resection time of 45 minutes and the mean blood loss during resection of 30 mL in their experience are remarkably excellent results. Another question is related to the resection time. Did this resection time they described include the time for radiofrequency coagulation or only time for liver parenchymal dissection or division?
There are a few questions regarding coagulative necrosis produced by radiofrequency energy. With their radiofrequency system, a core of coagulative necrosis of 1-cm radius (ie, 2-cm diameter) and 3 cm in depth was achieved in about 60 seconds. When they coagulated a cylinder of tissue 12 cm in depth (for example), the probe was withdrawn by 3 cm each time, requiring 4 applications. It means that they did not do overlapping coagulation on this line. I think it is necessary to perform overlapping coagulation on 1 line; otherwise, there will be some viable liver tissue left behind between each coagulation. Therefore, instead of withdrawing by 3 cm, it is likely necessary to withdraw by 1.5 to 2 cm. This overlapping coagulation requires more time to coagulate a cylinder of tissue 12 cm in depth: more than 4 applications and 4 minutes. I would like to know from the authors that overlapping coagulation was actually necessary or not.
In step 5 of their procedure, the authors divided the liver parenchyma 1 cm away from the tumor. They mentioned that this division would leave in situ 1 cm of burned coagulated surface. I do not think this assumption is true. They created coagulative necrosis of 1-cm radius (ie, 2-cm diameter). Therefore, if they divided the liver parenchyma as they described, there should be in situ 2-cm-wide coagulated surface left behind.
The most important question I have is regarding the method of application of coagulative necrosis in a curved fashion. In Figure 1 of their article, the steps were illustrated in 2 dimensions. In reality, we have to create coagulative necrosis in 3 dimensions. For example, if a tumor is located at the edge of lateral segment of the left lobe, a straight coagulation plane can be created relatively easily, as shown in steps 3 and 4 of their figure. However, if a tumor, particularly a large tumor, is located as shown in Figure 1 (eg, in the right lobe of the liver), the liver resection plane and coagulative necrosis plane need to be in a curved fashion. In such circumstances, how did they create the coagulative necrosis plane? If they made a straight plane rather than a curved plane, the resection margin would be very wide near the surface of the liver, while the margin would become close to the tumor in a deep area. I think, in some way, the coagulative necrosis and resection lines or planes need to be curved. This is particularly true when a tumor is located in a deep portion of liver parenchyma rather than the surface of the liver. To create a curved coagulative necrosis plane, did they apply the radiofrequency probe from different directions (not just from the anterior surface of the liver)? It would be easy to insert the probe from anterior or inferior surfaces of the liver; however, it would be difficult to insert the probe from the superior or posterior surfaces of the liver. It would be necessary to make the coagulation plane all the way around the tumor before dividing or dissecting the liver parenchyma to decrease or prevent significant blood loss. If they applied coagulative necrosis in halfway and then divided the liver parenchyma to create curved resection or coagulation planes (step by step), more significant bleeding might have been encountered because of the blood supply from noncoagulated liver parenchyma. Related to this, another question is that the division plane of the liver should be in the center of coagulative necrosis rather than the lateral edge of coagulative necrosis.
Radiofrequency energy with current thermal ablation devices can coagulate blood vessels up to 3 or 4 mm in diameter, I understand. When we perform hepatic resections, there are many blood vessels more than 3 or 4 mm in diameter encountered at the site of resection plane. Such large vessels cannot be coagulated easily by radiofrequency energy. I would like to know whether in their experiences they did not encounter any large vessels that needed to be ligated during the resection. If these large vessels could not be coagulated completely, blood loss during liver division would have been more than 30 mL, I assume. In addition, in the Discussion, the authors have mentioned that they believe it is possible to perform major resections after ligation of major blood vessels at the liver hilum. However, I doubt major resections can be performed with such small blood loss unless intraparenchymal large blood vessels are completely coagulated or ligated before division of the liver parenchyma.
In the Discussion, the authors have pointed out differences in coagulative necrosis time between normal liver parenchyma and liver tumor tissue. They have described that achieving coagulative necrosis in tumor tissue takes about 20 minutes, while it takes only 40 seconds to coagulate the same amount of normal liver tissue. This is totally different from my experiences, in which radiofrequency ablation (coagulative necrosis) of normal liver tissue takes almost the same time as required for ablation of liver tumors. Although hepatocellular carcinomas are often hypervascular, the majority of metastatic liver tumors are relatively hypovascular. Normal liver tissue is well vascularized compared with these metastatic liver tumors. Therefore, if the time for radiofrequency coagulative necrosis depends on vascular supply to the tissue, coagulative necrosis of normal liver tissue Annals of Surgery • Volume 241, Number 1, January 2005 Letter to the Editor would take time at least similar to time for coagulation of tumor tissue. I would like to know if there is any particular reason why it takes only such a short period to coagulate normal liver tissue in their experience. Did the authors use any other technique to shorten coagulative necrosis of normal liver tissue?
The new technique for liver resection using radiofrequency coagulative necrosis performed by Dr. Weber and colleagues would become an excellent method if it works as they described in their article. There must be more technical tips in performing their techniques, which I would like them to share by replying my questions. I and probably many hepatic surgeons would like to use this technique to reduce blood loss during hepatic resection and would appreciate the authors' providing more tech-
Polypropylene Mesh in Prevention of Postoperative Hernia in Bariatric Surgery
To the Editor: Lujan et al, 1 in their interesting study, have compared the results of laparoscopic (LapRGB) and open Rouxen-Y gastric bypass (RYGB). The number of arguments supporting the choice of LapRGB as a safer and less invasive method is gradually rising, but the open approach in bariatric surgery is still widely used. One of the obvious disadvantages of open procedure is an unacceptable rate of incisional hernia, having been reported as high as 25%. 2 Results of the Spanish study analyzing the complications of vertical band gastroplasty (VBG) in super obese patients showed even higher numbers. 3 We published the preliminary report on prophylactic use of polypropylene mesh in wound closure in RYGB surgery. 4 Until now, none of 12 reported patients with abdominal wall reinforced with the mesh developed incisional hernia. The mean BMI in this group was 52.9 Ϯ 6.1 kg/m 2 , and they were followed up for 24 to 60 months. Since the publication, we have used the mesh in more than 20 morbidly obese patients (mean BMI 54.6 Ϯ 7.2 kg/m 2 ), with similar good results. 5 The demand for bariatric surgery is still growing 6 as at present it is regarded as the most effective way of reducing and maintaining the body weight in the morbidly obese person. 7 The prophylactic use of polypropylene mesh in abdominal surgery as a solution for incisional hernia is gaining popularity. This method can be safely applied in those surgical operations which are encumbered with the high rate of incisional hernia (eg, abdominal aorta aneurysm repair 8 or cancer surgery in the elderly 9 ). The presence of open gut is not a contraindication to the prophylactic mesh use. A recently published Swedish study showed very good results of this technique as a prevention of parastomal hernia. 10 In summary, we believe that the rule "prevention is better than treatment" can be applied in the field of gastric bypass surgery, too. Laparoscopy is obviously the ultimate method of reduction of the incidence of abdominal wall hernia. However, for various reasons the large number of patients still undergoes open abdominal surgery. Until now, it seemed that the postoperative hernia was an unavoidable complication for a substantial number of morbidly obese in-dividuals. The introduction of a new application of a polypropylene mesh can substantially change this situation.
by a large number of surgeons and that to prevent hernias of the abdominal wall, a polypropylene mesh might be used prophylactically during closure of the laparotomy, thus preventing one of the major complications of this surgical technique and improving results when compared to laparoscopic surgery. However, the systematic use of a polypropylene mesh in the laparotomy closure of patients undergoing surgery for morbid obesity may prolong operating time, cause an increase in complications of the abdominal wall, such as seroma or infection of the surgical wound, and increase costs.
Furthermore, the advantages of laparoscopic surgery in morbid obesity over the open procedure include not only a reduction in incisional hernias but also all the other benefits as offered by minimally invasive surgery, such as greater comfort in the postoperative period, a short hospital stay and quick return to normal physical activities, and, in our study, a shorter operating time.
Moreover, the number of patients published by the authors is small and conclusions cannot be drawn for series with larger patients numbers, and a longer follow-up is needed to be able to assess the utility of the prophylactic use of polypropylene meshes in surgery for morbid obesity.
